Screener examples › Short Sellers & Contrarian
Deteriorating fundamentals
Short candidates: expensive and getting worse.
“Companies with EPS expected to fall next year, shrinking margins, a downtrend and high valuation”
Run this screen live and refine it in plain English (free, no sign-up).
US companies with consensus EPS expected to decline, contracting margins, a technical downtrend and rich valuation.
Filters: Expected EPS growth next FY < 0%; Gross margin change vs 1Y ago < 0; Operating margin change vs 1Y ago < 0; Price < SMA50 < SMA200; Expensive: fwd P/E vs industry, fwd P/E > 40 or EV/Sales > 15
Top matches on data as of October 26, 2026
| Symbol | Company | EPS Growth Next FY | Gross Margin Chg 1Y | Op Margin Chg 1Y | Price | SMA 50 | SMA 200 | Fwd P/E | Fwd P/E vs Industry |
|---|---|---|---|---|---|---|---|---|---|
| IVT | InvenTrust Properties Corp. | -15.4% | -20.1% | -1.5% | $30.09 | $31.17 | $32.07 | 274 | 7.1% |
| OLP | One Liberty Properties, Inc. | -68.6% | -56.0% | -26.7% | $22.32 | $22.94 | $23.18 | 58.74 | 2.5% |
| PPLI | People Incorporated | -82.5% | -1.6% | -2.5% | $38.19 | $39.03 | $40.58 | 34.23 | 2.0% |
| CSBR | Champions Oncology, Inc. | -100.0% | -2.1% | -10.4% | $4.86 | $4.97 | $5.79 | 48.6 | 144.9% |
| ORA | Ormat Technologies, Inc. | -5.5% | -1.0% | -4.0% | $87.13 | $96.49 | $112.03 | 35.77 | 142.0% |
5 matches. Research data, not investment advice.